Prostate Health Market Share 2021 Growth Challenges, Opportunities and Future Trends 2027
The global prostate health market is anticipated to grow at a considerable CAGR of 8.8% during the forecast period (2021-2027). The major factor attributing to the growth of the market is the high prevalence rate of prostate cancer. The increasing demand for prostate cancer drugs has driven the overall market. As a rsut of which market key players are inclined towards launching new drugs to cater increasing demand for advanced therapeutics for specific and effective treatment. For instance, in June 2021, Novartis announced that the FDA has granted Breakthrough Therapy designation (BTD) to 177Lu-PSMA-617, an investigational radioligand therapy for the treatment of metastatic castration-resistant prostate cancer (mCRPC). Breakthrough therapy designation was granted based on positive data from the pivotal, Phase III VISION study evaluating 177Lu-PSMA-617, a targeted radioligand therapy, plus standard of care (SOC), compared to SOC alone, in patients with progressive PSMA-positive mCRPC. The Phase III VISION study demonstrated that Lu-PSMA-617 significantly improved overall survival and radiographic progression-free survival for men with progressive PSMA-positive mCRPC.
To Request a Sample of our Report on Prostate Health
Market: https://www.omrglobal.com/request-sample/prostate-health-market
Further, in December 2020, FDA approved Orgovyx (relugolix)
for the treatment of adult patients with advanced prostate cancer. In a large
clinical trial, the drug was shown to be more effective at reducing
testosterone levels in men with advanced prostate cancer. Orgovyx is an orally
administered treatment that works by blocking the pituitary gland from making
hormones called luteinizing hormone and follicle-stimulating hormone, thereby
diminishing the amount of testosterone the testicles can make. The most
frequently reported side effects of Orgovyx included hot flush, increased
glucose and triglycerides, musculoskeletal pain, decreased hemoglobin, fatigue,
constipation, diarrhea, and increased liver enzyme levels.
In May 2020, Zydus Cadila
announced that it is launching Enzalutamide, a highly effective drug for the
treatment of Prostate Cancer, under the brand name 'Obnyx' in India. In a step
that can considerably reduce treatment cost by almost 70%.
Market Coverage
• The market number available for –
2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
·
By Disease Indication
·
By Treatment
• Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
•
Competitive Landscape- including Abbott
Laboratories, Amgen Inc., Astellas Pharma Inc., AstraZeneca, Bayer AG., BDR
Pharmaceuticals International Pvt. Ltd., and others.
(Get 15% Discount on
Buying this Report)
A
full Report of Prostate Health Market is Available at: https://www.omrglobal.com/industry-reports/prostate-health-market
Global Prostate Health Market Report Segment
By Disease Indication
• Prostate Cancer
• Benign Prostatic Hyperplasia
• Prostatitis
By Treatment
• Chemotherapy
• Biological Therapy
• Hormone Therapy
• Others
Global Prostate Health Market Report Segment by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment